Last update 08 May 2025

Adenovirus RSV-TK gene therapy(National Cancer Institute)

Overview

Basic Info

Drug Type
Gene therapy
Synonyms-
Target-
Action-
Mechanism
Gene transference
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal Diseases
Active Indication-
Inactive Indication
Malignant melanoma, metastaticMelanoma, Cutaneous Malignant
Originator Organization
National Cancer InstituteNational Cancer Institute
Active Organization-
Inactive Organization
National Human Genome Research InstituteNational Human Genome Research Institute
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Adenovirus RSV-TK gene therapy(National Cancer Institute)
NCT00005057
/ CompletedPhase 1IIT
A Phase I Study of Intralesional Administration of an Adenovirus Vector Expressing the HSV-1 Thymidine Kinase Gene (AdV.RSV-TK) in Combination With Escalating Doses of Ganciclovir in Patients With Cutaneous Metastatic Malignant Melanoma
100 Clinical Results associated with Adenovirus RSV-TK gene therapy(National Cancer Institute)
Login to view more data
100 Translational Medicine associated with Adenovirus RSV-TK gene therapy(National Cancer Institute)
Login to view more data
100 Patents (Medical) associated with Adenovirus RSV-TK gene therapy(National Cancer Institute)
Login to view more data
100 Deals associated with Adenovirus RSV-TK gene therapy(National Cancer Institute)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Malignant melanoma, metastaticPhase 1
United States
National Human Genome Research InstituteNational Human Genome Research Institute
01 Mar 2000
Melanoma, Cutaneous MalignantPhase 1
United States
National Human Genome Research InstituteNational Human Genome Research Institute
01 Mar 2000
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free